Biotech stocks that survived April 2 feel the heat of Trump’s new pharma threat
If you thought a 104% tariff on China was bad enough, Trump’s…
Csl Limited (ASX:CSL)
About Csl Limited
Key Information
CSL In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 05/08/2025 | Notification of cessation of securities - CSL | 12.65KB | 416 |
| 07/07/2025 | Notification of cessation of securities - CSL | 12.64KB | 495 |
| 17/06/2025 | CSL's Andembry FDA Approved | 128.44KB | 2.1K |
| 10/06/2025 | Appointment of New Director | 113.15KB | 1.0K |
| 04/06/2025 | Notification of cessation of securities - CSL | 12.65KB | 512 |
| 21/05/2025 | Notification of cessation of securities - CSL | 12.78KB | 489 |
| 08/05/2025 | Notification of cessation of securities - CSL | 12.64KB | 425 |
| 05/05/2025 | Shareholder Information Meetings | 3.95MB | 10K |
Share Price History
Officers & Directors
Insider Transactions
Frequently Asked Questions
|
What ASX sector is CSL?
CSL belongs to the Biotechnology sector. Their Principal Activity is the research, development, manufacture, marketing and distribution of biopharmaceutical and allied products.
|
|
When did CSL list on the ASX?
CSL has been listed on the ASX since 1994, following its conversion to a public company 100% owned by the Federal Government in 1991.
|
|
Where is CSL based?
CSL's head office is located in Melbourne, Australia, offering products and services globally.
|